Product Description: GD-9501-TFA is an auristatin S-based ADC linker with effective off-target toxicity characteristics, which can be used for the preparation of antibody-drug conjugates (ADCs)[1].
Applications: Cancer-programmed cell death
Formula: C68H104F3N11O16
References: [1]Payne K, et al. Process Development for the First GMP Synthesis of SGD-9501-TFA, Part 2: Synthesis of the Payload, Linker, and Drug Linker[J]. Organic Process Research & Development, 2024.
Molecular Weight: 1388.61
Research Area: Cancer
Target: ADC Linker